Clinical trials in "emerging markets": regulatory considerations and other factors.

Abstract

Clinical studies are being placed in emerging markets as part of global drug development programs to access large pool of eligible patients and to benefit from a cost effective structure. However, over the last few years, the definition of "emerging markets" is being revisited, especially from a regulatory perspective. For purposes of this article… (More)
DOI: 10.1016/j.cct.2013.09.006

Topics

Cite this paper

@article{Singh2013ClinicalTI, title={Clinical trials in "emerging markets": regulatory considerations and other factors.}, author={Romi Barat Singh and Ouhong Wang}, journal={Contemporary clinical trials}, year={2013}, volume={36 2}, pages={711-8} }